mk-3118 and Cross-Infection

mk-3118 has been researched along with Cross-Infection* in 1 studies

Other Studies

1 other study(ies) available for mk-3118 and Cross-Infection

Article	Year
Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor). International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Fungal; Glucosyltransferases; Glycosides; Humans; Microbial Sensitivity Tests; New York; Triterpenes	2020

Article

Year

Pan-resistant Candida auris isolates from the outbreak in New York are susceptible to ibrexafungerp (a glucan synthase inhibitor).

International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Fungal; Glucosyltransferases; Glycosides; Humans; Microbial Sensitivity Tests; New York; Triterpenes

2020